Stocktoria
LIFECORE BIOMEDICAL, INC. \DE\ LFCR
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 1996-02-15
LIFECORE BIOMEDICAL, INC. \DE\ financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $128.9M | $128.3M | $103.3M | $111.3M | $100.9M |
| Gross profit | $40.3M | $41.9M | $28.0M | $39.1M | $38.9M |
| R&D expense | $8.3M | $8.6M | $8.7M | $7.8M | $6.7M |
| SG&A expense | $44.0M | $40.5M | $39.0M | $34.7M | $27.7M |
| Operating income | -$17.2M | -$8.8M | -$21.8M | -$11.8M | -$8.8M |
| Interest expense | — | — | $17.6M | $15.6M | $8.9M |
| Income tax | $43,000 | $183,000 | $308,000 | -$5.2M | -$6.3M |
| Net income | -$38.7M | $12.0M | -$99.6M | -$116.7M | -$32.3M |
| EPS (diluted) | $-1.27 | $0.33 | $-3.32 | $-3.97 | $-1.10 |
| Operating cash flow | -$206,000 | $257,000 | -$17.4M | -$22.6M | $16.5M |
| Free cash flow | -$13.6M | -$18.1M | — | -$48.8M | -$2.8M |
| Cash & equivalents | $8.3M | $8.5M | $19.1M | $991,000 | $763,000 |
| Inventory | $32.3M | $40.0M | $40.8M | $36.0M | $33.9M |
| Total assets | $239.3M | $254.0M | $253.5M | $274.7M | $501.9M |
| Total liabilities | $191.9M | $200.1M | $218.5M | $186.9M | $299.9M |
| Shareholders' equity | $1.3M | $11.3M | -$4.2M | $87.8M | $201.9M |
Source: SEC EDGAR filings · CIK 0001005286 · as of 2025-05-25. Facts from filings plus Stocktoria's own computed scores — not investment advice.